KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Accumulated Expenses (2016 - 2026)

Teladoc Health's Accumulated Expenses history spans 13 years, with the latest figure at $60.7 million for Q1 2026.

  • On a quarterly basis, Accumulated Expenses rose 6.92% to $60.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $60.7 million, a 6.92% increase, with the full-year FY2025 number at $96.3 million, up 26.27% from a year prior.
  • Accumulated Expenses hit $60.7 million in Q1 2026 for Teladoc Health, down from $96.3 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for TDOC hit a ceiling of $102.7 million in Q4 2023 and a floor of $39.1 million in Q3 2022.
  • Historically, Accumulated Expenses has averaged $66.0 million across 5 years, with a median of $66.4 million in 2024.
  • The widest YoY moves for Accumulated Expenses: up 2657.07% in 2022, down 48.51% in 2022.
  • Tracing TDOC's Accumulated Expenses over 5 years: stood at $81.6 million in 2022, then rose by 25.91% to $102.7 million in 2023, then decreased by 25.76% to $76.2 million in 2024, then grew by 26.27% to $96.3 million in 2025, then crashed by 36.97% to $60.7 million in 2026.
  • Business Quant data shows Accumulated Expenses for TDOC at $60.7 million in Q1 2026, $96.3 million in Q4 2025, and $76.8 million in Q3 2025.